COYA
Coya Therapeutics Inc
Clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory T cells (Tregs) for treatment of neurodegenerative, autoimmune, and metabolic diseases
CUSIP: 22407B108HealthcareUS1 holder
Total Value
$1.86M
Total Shares
392.4K
Net Share Change
+392.4K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Greenlight Capital
$1.86M392.4K sharesNEW